Structured Exercise Improves Cognitive Function and Reduces Aging Markers in Cancer Survivors
A 12-month randomized clinical trial involving 253 breast cancer survivors found that a supervised exercise program improved attention and memory performance compared to a wellness control group. The study also indicates that regular physical activity may slow epigenetic aging—changes in gene expression patterns associated with biological aging—in cancer survivors. These findings suggest structured exercise interventions can address cancer-related cognitive impairment and potentially reverse some aging-related molecular changes.
Cancer treatment often produces lasting cognitive side effects that compromise survivors' daily functioning and quality of life. These impairments stem from multiple biological pathways including inflammatory responses, hormonal disruption, and treatment toxicity, making them challenging to address through conventional medical approaches.
The research team evaluated whether structured physical activity could reverse these effects by examining both cognitive performance and molecular aging markers. Over the year-long intervention, participants using fitness trackers and personalized coaching achieved clinically meaningful gains in attention that persisted at follow-up, while blood analysis revealed slowed epigenetic aging—suggesting exercise may influence fundamental biological aging processes at the cellular level.
These findings could influence rehabilitation protocols for the growing population of cancer survivors seeking to manage long-term treatment effects. If validated further, structured exercise programs might become standard clinical recommendations, potentially reducing healthcare burdens and improving quality of life without pharmaceutical intervention. The connection between physical activity and epigenetic aging may also inform broader aging research and prevention strategies for non-cancer populations, though additional studies would be needed to confirm generalizability across different survivor groups and treatment types.